Amanote Research

Amanote Research

    RegisterSign In

Understanding the Burden of Refractory Myasthenia Gravis

Therapeutic Advances in Neurological Disorders - United Kingdom
doi 10.1177/1756286419832242
Full Text
Open PDF
Abstract

Available in full text

Categories
NeurologyPharmacology
Date

January 1, 2019

Authors
Christiane Schneider-GoldTim HagenackerNico MelzerTobias Ruck
Publisher

SAGE Publications


Related search

Refractory Myasthenia Gravis – Patient Burden and the Need for New Therapeutic Targets

European Neurological Review
Neurology
2018English

Treatment for Refractory Myasthenia Gravis.

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
1989English

Escalation Strategies in the Treatment of Refractory Myasthenia Gravis

Neurology International Open
2018English

Refractory Myasthenia Gravis: Clinical Description and Literature Review

Scholars Journal of Applied Medical Sciences
2020English

Employment in Refractory Myasthenia Gravis: An Mgfa Registry Analysis

Muscle and Nerve
Molecular NeuroscienceNeurologyPhysiologyCellular
2019English

Long-Term Treatment of Refractory Myasthenia Gravis With Subcutaneous Immunoglobulin

Therapeutic Advances in Neurological Disorders
NeurologyPharmacology
2017English

Myasthenia Gravis

CMAJ
Medicine
2018English

Myasthenia Gravis

Postgraduate Medical Journal
Medicine
1965English

Myasthenia Gravis

Seminars in Neurology
Neurology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy